DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Gabelli Funds LLC

Gabelli Funds LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 55.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 97,000 shares of the medical instruments supplier's stock after selling 120,500 shares during the period. Gabelli Funds LLC's holdings in DENTSPLY SIRONA were worth $1,841,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of XRAY. Riverview Trust Co acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB boosted its holdings in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after acquiring an additional 1,232 shares during the last quarter. UMB Bank n.a. grew its position in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after acquiring an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after acquiring an additional 1,568 shares during the last quarter. Finally, Signaturefd LLC raised its holdings in shares of DENTSPLY SIRONA by 513.3% in the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after purchasing an additional 3,706 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $12.83 on Friday. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $31.00. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a market cap of $2.56 billion, a P/E ratio of -6.20, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The stock has a 50 day moving average of $15.72 and a 200-day moving average of $18.82.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.99%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier purchased 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.52% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on XRAY shares. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Mizuho cut their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Thursday, March 13th. Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Thirteen analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $22.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.